Literature DB >> 7768105

(-)-Deprenyl increases the survival of rat retinal ganglion cells after optic nerve crush.

Y M Buys1, G E Trope, W G Tatton.   

Abstract

Retinal ganglion cells (RGCs) have been shown to die by apoptosis after damage to their axons caused by optic nerve crush and the death can be reduced by some neurotrophic factors. Since (-)-deprenyl can reduce apoptotic death in some neuronal systems, we determined whether it can increase RGC survival after optic nerve crush. Fluoro-Gold (FG), a fluorescent retrograde tracer, was injected into both superior colliculi to pre-label RGC cells bodies in the retinal ganglion cell layers (RGCLs) of adult Sprague-Dawley rats. Fours days later, the left optic nerve was crushed immediately behind the globe and the animals received either (-)-deprenyl (1 mg/kg) or saline by intraperitoneal injection every two days for 14 days. Nissl stained neuronal cell bodies per mm of section length of RGCL were counted from serial frozen sections. The number of RGCL cell bodies sending axons to the superior colliculi (RGCSCS) were identified by FG fluorescence as a means of determining the proportion of RGCL neurons (RGCLns) that were RGCSCS. In the uncrushed retinas an average of 40.7% of the RGCLns were found to be RGCSCS. There was no difference in RGCSCS/mm between the uncrushed treated with saline group and the uncrushed group treated with (-)-deprenyl group. The optic nerve crush with saline group showed a decrease in RGCSCS to 3.0 +/- 1.0% of the uncrushed saline group while the optic nerve crush with (-)-deprenyl group showed a considerably smaller decrease in RGCSCS to 36.9 +/- 11.2% of the uncrushed saline group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768105     DOI: 10.3109/02713689508999923

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

1.  Protein aggregation in retinal cells and approaches to cell protection.

Authors:  Irina Surgucheva; Natalia Ninkina; Vladimir L Buchman; Kenneth Grasing; Andrei Surguchov
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

2.  Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat.

Authors:  Z Speiser; A Mayk; L Litinetsky; T Fine; A Nyska; E Blaugrund; S Cohen
Journal:  J Neural Transm (Vienna)       Date:  2006-12-21       Impact factor: 3.575

Review 3.  90 years of monoamine oxidase: some progress and some confusion.

Authors:  Keith F Tipton
Journal:  J Neural Transm (Vienna)       Date:  2018-04-10       Impact factor: 3.575

4.  Neuroprotective effects of cardiotrophin-like cytokine on retinal ganglion cells.

Authors:  Frank Schuettauf; David Zurakowski; Kristine Quinto; Meghana A Varde; Dorothea Besch; Alan Laties; Ralph Anderson; Rong Wen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

Review 5.  Inducible rodent models of glaucoma.

Authors:  Iok-Hou Pang; Abbot F Clark
Journal:  Prog Retin Eye Res       Date:  2019-09-23       Impact factor: 21.198

6.  Neuroprotection by pharmacologic blockade of the GAPDH death cascade.

Authors:  Makoto R Hara; Bobby Thomas; Matthew B Cascio; Byoung-Il Bae; Lynda D Hester; Valina L Dawson; Ted M Dawson; Akira Sawa; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

7.  Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures.

Authors:  D E Schmidt; M H Ebert; J C Lynn; W O Whetsell
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 8.  [Mechanisms of neuroprotection against glaucoma].

Authors:  T Mittag; K-G Schmidt
Journal:  Ophthalmologe       Date:  2004-11       Impact factor: 1.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.